A high incidence of vertebral fracture in women with breast cancer (original) (raw)
References
Breast Cancer Task Force. Treatment Committee. National Cancer Institute, Breast Cancer (1977). Suggested protocol guidelines for combination chemotherapy trials and for combined modality trials. Washington, DC, US Department of Health, Education and Welfare. Publication no. (NIH) 77–1192.
Filipponi, P., Christallini, S., Rizzello, E., Policani, G., Fedeli, L. & Gregorio, F. et al (1996). Cyclical intravenous clodronate in postmenopausal osteoporosis. Results of a long-term trial. Bone18: 179–184. ArticleCAS Google Scholar
Hayward, J. L., Meakin, J. W. & Stewart, H. J. (1978). Assessment of response and recurrence in breast cancer. Semin Oncol5: 445–449. CASPubMed Google Scholar
Kanis, J. A., Powles, T., Paterson, A. H. G., McCloskey, E. V. & Ashley, S. (1996). Clodronate decreases the frequency of skeletal metastases in women with breast cancer. Bone19: 663–667. ArticleCAS Google Scholar
Kanis, J. A., Delmas, P., Burckhardt, P. Cooper, C. & Torgerson D., on behalf of the EFFO (1997). Guidelines for the diagnosis and management of osteoporosis. Osteoporosis Int7: 390–406. ArticleCAS Google Scholar
McCloskey, E. V., Spector, T. D., Eyres, K. S., Fern, D. E., O’Rourke, N., Vasikaran, S. & Kanis, J. A. (1993). The assessment of vertebral deformity – a method for use in population studies and clinical trials. Osteoporosis Int3: 138–147. ArticleCAS Google Scholar
Orloff, J. J., Wu, T. L. & Stewart, A. F. (1989). Parathyroid hormone-like proteins: biochemical responses and receptor interactions. Endocrinol Rev10: 476–495. ArticleCAS Google Scholar
Paterson, A. H. G., Powles, T. J., Kanis, J. A., McCloskey, E., Hanson, J. & Ashley, S. (1993). Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol11: 59–65. ArticleCAS Google Scholar
Powell, G. J., Southby, J., Danks, J. A., Stillwell, R. G., Hayman, J. A. & Henderson, M. A. et al (1991). Localisation of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res51: 3059–3061. CASPubMed Google Scholar
Powles, T. J., Hickish, T., Kanis, J. A., Tidy, A. & Ashley, S. (1996). The effect of tamoxifen on lumbar bone mineral density in pre- and postmenopausal women. J Clin Oncol14: 78–84. ArticleCAS Google Scholar
Powles, T. J., McCloskey, E., Paterson, A. H. G., Ashley, S., Tidy, A. & Kanis, J. A. (1997). Oral clodronate reduces the loss of bone mineral density in women with operable primary breast cancer. J Clin Oncol, submitted for publication, ASBMR abstract,
Rivkees, A. S. & Crawford, J. D. (1988). The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA259: 2123–2125. ArticleCAS Google Scholar
Saarto, T., Blomqvist, C., Valimaki, M., Makelo, P., Sarna, S. & Elomaa, I. (1997). Chemical castration induced by adjuvant cyclophosphamide, methotrexate and fluorouracil chemotherapy causes rapid bone loss that is reduced by clodronate: a randomised study in premenopausal breast cancer patients. J Clin Oncol15: 1341–1347. ArticleCAS Google Scholar
Spector, T. D., McCloskey, E., Doyle, D. V. & Kanis, J. A. (1993). Prevalence of vertebral fractures in women and the relationship with bone density and symptoms. The Chingford study. J Bone Miner Res8: 817–822. ArticleCAS Google Scholar
Taube, T., Elomaa, I., Blomqvist, C., Beneton, M. N. C. & Kanis, J. A. (1994). Histomorphometric evidence for osteoclast mediated bone resorption in metastatic breast cancer. Bone15: 161–166. ArticleCAS Google Scholar
Utz, J. P., Melton, L. J., Kan, S. H. & Riggs, B. L. (1987). Risk of osteoporotic fractures in women with breast cancer: a population-based cohort study. J Chron Dis40: 105–113. ArticleCAS Google Scholar